Table 2.

Changes in vessel wall dimensions from baseline to end-of-follow-up as assessed by MRI.

	Lumen Area	Vessel Wall Area
OVX (n=12)	−1.2 ± 7.5%	−1.9 ± 3.4%
Low RLX (n=12)	−0.5 ± 13.5%	−4.8 ± 6.4%
High RLX (n=12)	−1.4 ± 17.4%	−6.2 ± 6.6%
All RLX (n=24)	−0.9 ± 10.7%	−5.5 ± 4.5% *

All values expressed as the percent change ± SEM between baseline (at randomization) and end-of-follow-up.

^*p<0.05 versus baseline.

OVX: ovariectomized control group; RLX: raloxifene therapy group (Low: low-dose, High: high-dose).